KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Treasury Shares (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Treasury Shares for 17 consecutive years, with $5.2 billion as the latest value for Q4 2025.

  • Quarterly Treasury Shares rose 6.65% to $5.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.2 billion through Dec 2025, up 6.65% year-over-year, with the annual reading at $5.2 billion for FY2025, 6.65% up from the prior year.
  • Treasury Shares hit $52.0 million in Q4 2025 for Quest Diagnostics, up from $51.0 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $52.0 million in Q4 2025 to a low of $1.0 million in Q4 2021.
  • Historically, Treasury Shares has averaged $24.9 million across 5 years, with a median of $10.8 million in 2021.
  • Biggest five-year swings in Treasury Shares: crashed 44.47% in 2021 and later skyrocketed 49.02% in 2022.
  • Year by year, Treasury Shares stood at $3.5 billion in 2021, then surged by 35.33% to $4.7 billion in 2022, then rose by 3.27% to $4.8 billion in 2023, then increased by 0.64% to $4.9 billion in 2024, then rose by 6.65% to $5.2 billion in 2025.
  • Business Quant data shows Treasury Shares for DGX at $5.2 billion in Q4 2025, $4.9 billion in Q3 2025, and $4.8 billion in Q2 2025.